| scholarly article | Q13442814 |
| P50 | author | Nicholas Talley | Q7026286 |
| Alan R. Zinsmeister | Q64368056 | ||
| David Katzka | Q87824496 | ||
| Cathy D. Schleck | Q114082044 | ||
| Tsung-Teh Wu | Q114439535 | ||
| Yvonne Romero | Q114776260 | ||
| Lori S Lutzke | Q115607420 | ||
| Ganapathy A Prasad | Q115607457 | ||
| Kelly T Dunagan | Q115607463 | ||
| P2093 | author name string | Kenneth K Wang | |
| Kee Wook Jung | |||
| G Richard Locke | |||
| Debra M Geno | |||
| Mary Frederickson | |||
| P2860 | cites work | Normalization of intestinal metaplasia in the esophagus and esophagogastric junction: incidence and clinical data | Q31083667 |
| Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data | Q31919142 | ||
| Is there publication bias in the reporting of cancer risk in Barrett's esophagus? | Q33993884 | ||
| Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings | Q34037852 | ||
| Prevalence of metaplasia at the gastro-oesophageal junction | Q34059892 | ||
| Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus | Q34761782 | ||
| Relative risk of dysplasia for patients with intestinal metaplasia in the distal oesophagus and in the gastric cardia | Q35358348 | ||
| Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota | Q35565680 | ||
| Increasing incidence of Barrett's oesophagus in the general population | Q35598185 | ||
| Intestinal metaplasia at the gastroesophageal junction | Q35648638 | ||
| A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. | Q35827411 | ||
| The use of cytokeratin stain to distinguish Barrett's esophagus from contiguous tissues: a systematic review | Q36764795 | ||
| A computer program package for relative survival analysis | Q38521260 | ||
| Adenocarcinomas of the distal esophagus and "gastric cardia" are predominantly esophageal carcinomas | Q46053658 | ||
| The Development and Validation of an Endoscopic Grading System for Barrett’s Esophagus: The Prague C & M Criteria | Q58104636 | ||
| Barrett's esophagus: age, prevalence, and extent of columnar epithelium | Q67555293 | ||
| Histological findings after routine biopsy at the gastro-oesophageal junction | Q73187200 | ||
| The Z-line appearance and prevalence of intestinal metaplasia among patients without symptoms or endoscopical signs indicating gastroesophageal reflux | Q74156093 | ||
| The changing incidence of oesophageal and gastric adenocarcinoma by anatomic sub-site | Q79706343 | ||
| Which landmark results in a more consistent diagnosis of Barrett's esophagus, the gastric folds or the palisade vessels? | Q79963424 | ||
| The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence | Q81290009 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Barrett's esophagus | Q808892 |
| P304 | page(s) | 1447-55; quiz 1456 | |
| P577 | publication date | 2011-04-12 | |
| P1433 | published in | The American Journal of Gastroenterology | Q7713501 |
| P1476 | title | Epidemiology and natural history of intestinal metaplasia of the gastroesophageal junction and Barrett's esophagus: a population-based study | |
| P478 | volume | 106 |
| Q35291922 | A randomized comparative effectiveness trial of novel endoscopic techniques and approaches for Barrett's esophagus screening in the community |
| Q40365358 | ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus |
| Q34352867 | Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysis |
| Q34315153 | Alcohol consumption and the neoplastic progression in Barrett's esophagus: a systematic review and meta-analysis |
| Q38328606 | Australian clinical practice guidelines for the diagnosis and management of Barrett's esophagus and early esophageal adenocarcinoma |
| Q27332349 | BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia |
| Q95488201 | Barrett oesophagus |
| Q64121949 | Barrett's esophagus: novel strategies for screening and surveillance |
| Q38230762 | Barrett's oesophagus patients with low-grade dysplasia can be accurately risk-stratified after histological review by an expert pathology panel |
| Q41191034 | Barrett's oesophagus: Current controversies |
| Q34380645 | British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus |
| Q40396082 | Cancer incidence and mortality risks in a large US Barrett's oesophagus cohort |
| Q98726725 | Chemoprevention of esophageal adenocarcinoma |
| Q49712756 | Comparative Assessment of Patient Preferences and Tolerability in Barrett Esophagus Screening: Results From a Randomized Trial |
| Q34603498 | Comparative acceptability of transnasal esophagoscopy and esophageal capsule esophagoscopy: a randomized, controlled trial in veterans |
| Q38005810 | Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process |
| Q30619561 | Cost-effectiveness of chemoprevention with proton pump inhibitors in Barrett's esophagus |
| Q37055792 | Diagnosis and management of Barrett's esophagus |
| Q41550041 | Diagnosis and management of Barrett's metaplasia: What's new |
| Q36038972 | Dietary fruit, vegetable, fat, and red and processed meat intakes and Barrett's esophagus risk: a systematic review and meta-analysis |
| Q26825742 | Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma |
| Q44629348 | Gastroparesis on the rise: incidence vs awareness? |
| Q88417213 | How Should We Report Endoscopic Results in Patient's with Barrett's Esophagus? |
| Q87916891 | IMportance of an Irregular Z Line: Is Barrett's in the Eye of the Beholder? |
| Q35891829 | Improvement over time in outcomes for patients undergoing endoscopic therapy for Barrett's oesophagus-related neoplasia: 6-year experience from the first 500 patients treated in the UK patient registry |
| Q47619259 | Incidence and predictors of osteoporotic fractures in patients with Barrett's oesophagus: a population-based nested case-control study |
| Q39739602 | Increasing incidence of Barrett's oesophagus: a population-based study |
| Q37166908 | Metabolic syndrome as a risk factor for Barrett esophagus: a population-based case-control study |
| Q88687901 | Molecular Evolution of Metaplasia to Adenocarcinoma in the Esophagus |
| Q35586353 | Population screening for barrett esophagus: a prospective randomized pilot study |
| Q48601841 | Prevalence and predictors of columnar lined esophagus in gastroesophageal reflux disease (GERD) patients undergoing upper endoscopy. |
| Q38214785 | Progression of Barrett oesophagus: role of endoscopic and histological predictors |
| Q36245569 | Proton Pump Inhibitors Do Not Reduce the Risk of Esophageal Adenocarcinoma in Patients with Barrett's Esophagus: A Systematic Review and Meta-Analysis |
| Q36764087 | Quality indicators for the management of Barrett's esophagus, dysplasia, and esophageal adenocarcinoma: international consensus recommendations from the American Gastroenterological Association Symposium |
| Q48034452 | Quality of life of esophagectomized patients: adenocarcinoma versus squamous cell carcinoma |
| Q35998193 | Radiofrequency Ablation Is Associated With Decreased Neoplastic Progression in Patients With Barrett's Esophagus and Confirmed Low-Grade Dysplasia |
| Q37018314 | Rates and predictors of progression to esophageal carcinoma in a large population-based Barrett's esophagus cohort |
| Q50057605 | Recent Advances in Screening for Barrett's Esophagus. |
| Q26864783 | Recent developments in pathogenesis, diagnosis and therapy of Barrett's esophagus |
| Q38141855 | Review on novel concepts of columnar lined esophagus |
| Q48256242 | Risk of Neoplastic Progression Among Patients with an Irregular Z Line on Long-Term Follow-Up. |
| Q36783294 | Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study |
| Q37621036 | Role of chemoprophylaxis with either NSAIDs or statins in patients with Barrett's esophagus |
| Q34624586 | Screening for Barrett's esophagus and esophageal adenocarcinoma: rationale, recent progress, challenges, and future directions |
| Q35291906 | Screening for Barrett's esophagus: results from a population-based survey |
| Q34324864 | Statins are associated with reduced risk of esophageal cancer, particularly in patients with Barrett's esophagus: a systematic review and meta-analysis |
| Q38219587 | Surveillance for low-grade dysplastic Barrett's oesophagus: one size fits all? |
| Q38771931 | The Genetics of Barrett's Esophagus: A Familial and Population-Based Perspective |
| Q37227732 | The characterization of an intestine-like genomic signature maintained during Barrett's-associated adenocarcinogenesis reveals an NR5A2-mediated promotion of cancer cell survival. |
| Q43756856 | The dose of omeprazole required to achieve adequate intraesophageal acid suppression in patients with gastroesophageal junction specialized intestinal metaplasia and Barrett's esophagus |
| Q93355900 | The incidence of esophageal cancer and dysplasia in a Chinese population with nondysplastic Barrett's esophagus |
| Q34542075 | The role of tobacco, alcohol, and obesity in neoplastic progression to esophageal adenocarcinoma: a prospective study of Barrett's esophagus |
| Q26751160 | Update on management of Barrett's esophagus |
| Q38940516 | What Makes an Expert Barrett's Histopathologist? |
| Q36264943 | Yield of Repeat Endoscopy in Barrett's Esophagus with No Dysplasia and Low-Grade Dysplasia: A Population-Based Study |
Search more.